Presenting on Emerging Growth Conference 87 Day 1 on October 22. Register to live stream.

(NASDAQ:IMRN),(Other OTC:AFDG),(NYSE Arca:VGZ),(TSX:VGZ),(NYSE:CIA),(NasdaqGM:CRVO),(OTCQB:CYBHF),(TSX-V:CYBE),(OTCQB:COPAF),(TSX-V:CPAU),(OTCQB:WRLGF),(TSX-V:WRLG),(OTCQB:CUAUF),(TSX-V:CCCM),(Other OTC:BSAI),(PinkSheets:KBRIF),(TSX-V:KRI),(NYSE Arca:ATCH), MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 87th Emerging Growth Conference on October 22 & 23, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & […]

VxLabs Launches ThreatZ, an AI-Powered Automotive Cybersecurity & Compliance Platform for ISO/SAE 21434 and UNECE R155

Start-up company leverages AI innovations to advance cybersecurity for connected vehicles & supply chains VxLabs- Shielding Innovation and Securing Mobility – announces ThreatZ, a next-generation cybersecurity management and compliance platform that uses AI to help automotive security teams move with speed, efficiency, and consistency to protect connected, autonomous, and software-defined vehicles in a rapidly evolving

Tonix Pharmaceuticals to Present Poster on Tonmya(TM) at the 2025 American College of Rheumatology (ACR) Convergence

(NASDAQ:TNXP), CHATHAM, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated, commercial biotechnology company, announced today that a poster on Tonmya(TM) (cyclobenzaprine HCl sublingual tablets), which was investigated as TNX-102 SL, will be presented by Dr. Gregory Sullivan, M.D., Chief Medical Officer of Tonix Pharmaceuticals,

iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek(R) and PEGS Europe 2025

(NASDAQ:IBIO), SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) — iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that Cory Schwartz, Ph.D., Director of Research and Early Development at iBio, will deliver an oral presentation at ObesityWeek 2025 November 4-7 in Atlanta. In addition, Martin Brenner, DVM, Ph.D., Chief Executive Officer and

Standing Behind Our Suspension Ferris Announces Two New Programs To Support Landscapers, Homeowners And Dealers

Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Ferris is introducing a new industry-leading, 10-year suspension warranty with a 24-hour suspension parts guarantee, making this the longest suspension warranty in the industry. Worry-free 10-year suspension warranty: Proof that it's built to lastFerris was the first to engineer full suspension for riding mowers and we remain

Vanguard to Showcase Advanced Battery Technology and Enhanced Engine Lineup at Equip Exposition 2025

Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Vanguard will showcase its powerful lineup of commercial gas engines and battery solutions at the Equip Exposition in Louisville, Kentucky, from October 22-24. As a trusted power expert, for original equipment manufacturers (OEMs), Vanguard will display its latest innovations as part of the Briggs & Stratton exhibit

Vanguard Battery Technology Powers FIRSTGREEN Industries’ Innovative MiniZ Electric Loader

Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Briggs & Stratton is showcasing the power and durability of its Vanguard(TM) 48V 7kWh(1) Commercial Battery (Fi7.0) through a real-world application with its partner FIRSTGREEN Industries, an innovator in electric heavy equipment. The result is the MiniZ, a powerful and compact electric tracked loader designed for demanding

Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy

(NasdaqGM:CLYM), WELLESLEY HILLS, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has strengthened its leadership team with the appointments of Adam Villa as Senior Vice President, Technical Operations, and Ashley Jones as Senior Vice President, People & Workforce

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress

(NASDAQ:EXEL),(NASDAQ:LEGN),(NASDAQ:AKRO), DUBLIN and OXFORD, United Kingdom and PHILADELPHIA, Oct. 21, 2025 (GLOBE NEWSWIRE) — SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced the appointments of Charles “Chip” R. Romp and Tom J. Heyman to its Board of Directors. These appointments further align SynOx's business

Billy Goat Unveils Next-Generation Hurricane(TM) Stand-On Blowers: The Z3002 and X3002

Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Billy Goat is pleased to announce the launch of the new Z3002 and X3002 Hurricane(TM) Stand-On Blowers. These models are built upon the robust performance of the prior 3001 series, incorporating significant new and carried-over upgrades focused on increasing durability, enhancing operator comfort, and improving ease of

Scroll to Top